Clinical Trials Detail

Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

A Ph.3 Randomized Study of Nivolumab + Ipilimumab vs. Nivolumab for Previously Treated Patients with St.IV Squamous Cell Lung Cancer and No Matching Biomarker

Objective
CategoryInformation
Study #: S1400I – Lung MAP
Anatomic Site: Lung
Histology: Squamous
Mutation: None
Stage: Stage IV
Treatment Phase: Must have completed at least one round of treatment
Location:
Study Link: https://clinicaltrials.gov/ct2/show?term=S1400I&rank=1

Clinical Trial Categories

  • Lung